T3 Defense (DFNS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Jun, 2026Executive summary
Special Meeting scheduled for June 18, 2026, to vote on four key proposals related to securities issuance and corporate structure changes.
Proposals address compliance with Nasdaq rules, capital structure flexibility, and maintaining listing requirements.
Board unanimously recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Proposal One: Approve issuance of common stock upon exercise of warrants from the February 2026 Private Placement, potentially exceeding 20% of outstanding shares.
Proposal Two: Approve issuance of common stock upon conversion of Series B Preferred Stock, waiving the 19.99% Preferred Exchange Cap.
Proposal Three: Grant Board authority for 18 months to enact a reverse stock split at a ratio between 1-for-2 and 1-for-250.
Proposal Four: Approve adjournment of the meeting to solicit additional proxies if needed.
Each proposal has specific voting thresholds and effects on shareholder rights and capital structure.
Board of directors and corporate governance
Board has fixed May 21, 2026, as the record date for voting eligibility.
Directors and executive officers have no substantial interests in the proposals beyond their share ownership.
Board recommends voting “FOR” all proposals.
Latest events from T3 Defense
- Stockholders to vote on an adjusted equity incentive plan after a 1:125 reverse stock split.DFNS
Proxy filing16 Jul 2026 - Vote to approve a 22M-share equity plan with annual increases, unaffected by imminent stock split.DFNS
Proxy filing14 Jul 2026 - Annual meeting to vote on directors, auditor, equity plan, and adjournment, all board-recommended.DFNS
Proxy filing10 Jul 2026 - Registration covers up to 30M shares for resale, including private placement, with legal and SEC compliance confirmed.DFNS
Registration filing25 Jun 2026 - Shareholders approved warrant issuance, preferred conversion, and reverse split amid stock price concerns.DFNS
EGM 202624 Jun 2026 - Share issuances and capital structure changes drive key proposals and future equity sale risks.DFNS
Proxy filing17 Jun 2026 - IPO enables resale of 30M shares amid high dilution, defense pivot, and major execution risks.DFNS
Registration filing4 Jun 2026 - Aims for 30–40% annual growth and a billion-dollar valuation via defense sector acquisitions.DFNS
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference4 Jun 2026 - Poised for growth with $26M 2026 revenue guidance and a focus on next-gen defense technologies.DFNS
Investor presentation4 Jun 2026